Table 3. Conditions for differentiating iTfh0, iTfh1, iTfh2, and iTfh17 Cells.
Cell type | Cytokines | Neutralizing antibodies |
---|---|---|
iTh0 | No cytokines | No antibodies |
iTh1 | 20 ng/ml IL-12 | Anti-IL-4, anti-TGF-β |
iTh2 | 50 ng/ml IL-4 | Anti-IFN-γ, anti-TGF-β |
iTh17 | 50 ng/ml IL-6, 2 ng/ml TGF-β | Anti-IFN-γ, anti-IL-4 |
iTfh1 | 100 ng/ml IL-6, 50 ng/ml IL-21, 1 ng/ml IL-12 | Anti-IL-4, anti-TGF-β |
iTfh2 | 100 ng/ml IL-6, 50 ng/ml IL-21, 20 ng/ml IL-4 | Anti-IFN-γ, anti-TGF-β |
iTfh17 | 100 ng/ml IL-6, 50 ng/ml IL-21, 0.1 ng/ml TGF-β | Anti-IFN-γ, anti-IL-4 |